RNU7-20P

Across TCGA pan-cancer cohorts, RNU7-20P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU7-20P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-20P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-20P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, KIRC, and LIHC are the cancer types where RNU7-20P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.073	0.694	<.001	117	view →
KIRC	DFS	Tertile	IV	0.083	0.641	<.001	36	view →
LIHC	OS	Tertile	III,IV	0.104	0.663	<.001	36	view →
THYM	DFS	Tertile	II,III,IV	0.207	0.768	.008	27	view →
OV	DFS	Tertile	III,IV	0.418	0.545	.035	18	view →
SKCM	DFS	Tertile	All	0.088	0.757	<.001	18	view →
GBM	DFS	Tertile	All	0.092	0.304	.005	9	view →
KIRP	DFS	Tertile	II,III,IV	0.181	0.693	.020	9	view →
ESCA	OS	Tertile	II,III,IV	0.656	0.441	.035	8	view →
LUSC	DFS	Quartile	III,IV	0.304	0.842	.005	7	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU7-20P–BLCA (OS)

Open the BLCA breakdown →